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INTRODUCTION
Bariatric surgery has become the standard treat-
ment for morbidly obese subjects as it leads to sig-
nificant weight loss and control of comorbidities in 
most cases. Overall impact of surgery on long term 
mortality reduction has already been observed on 
obese patients with 40% reduction on all causes mor-
tality, 56% on coronary heart disease, 92% on diabetes 
complications and 60% on any type of cancer(1).
Nevertheless, some individuals may regain variable 
amounts of weight after a period of rapid weight loss, 
while others fail to lose significant weight despite the 
major structural and physiological changes brought 
by the surgery(22). Hence, postsurgical weight loss 
failure constitutes a major concern since it is poorly 
understood and brings unsatisfactory outcomes and 
possible need of further interventions(12).
OBJECTIVE
To evaluate which preoperative predictors are 
associated with weight loss failure following Roux-
en-Y gastric bypass.
METHODS
It is a retrospective cohort study which enrolled 
subjects who underwent open Roux-en-Y gastric 
bypass (RYGB) at Hospital de Clinicas - UNICAMP 
between 2009 and 2011. This study was submitted 
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and approved by the local Research Ethics Commit-
tee. RYGB was indicated according to the National 
Institutes of Health Consensus Statement criteria(8). 
Estimation of sample size was performed using sin-
gle-proportion formula with 95% confidence interval. 
Precision was set at 10% and the calculated sample 
size was 87. Exclusion criteria were: subjects who 
belonged to vulnerable groups (mentally ill, institu-
tionalized, or aged below 18 years old), postoperative 
follow-up below 24 months, patients who underwent 
other bariatric procedures after RYGB; patients who 
developed consumptive and/or oncologic diseases 
following RYGB.
The main characteristics regarding demograph-
ics, anthropometric parameters, presence of  type 2 
diabetes mellitus (T2DM) and hypertension, and 
insulin usa ge were assessed. Preoperative weight and 
body mass index (BMI) were evaluated on the day 
the surgery was carried out; postoperative weight and 
BMI were evaluated 24 months following surgery. Per-
centage of excess weight loss (%EWL) was calculated 
according to the formula below:
%EWL = [preoperative weight – follow-up weight] / 
[preoperative weight – ideal weight] * 100
A postsurgical percentage of  weight loss below 
50% of excess body weight after 24 months was con-
sidered weight loss failure as previously reported by 
Reinhold(19). Comparisons were made between the 
groups (adequate weight loss vs weigh loss failure) 
in order to identify possible variables associated to 
this outcome.
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Statistical analysis
The baseline characteristics of patients are described and 
then compared with postoperative period. Data were exam-
ined for normality according to the Pearson’s chi-squared 
test. For univariate analysis of  categorical variables, chi-
square and Fisher’s exact tests were carried out. Mann-Whit-
ney test was used to compare continuous measures between 
independent groups. The significance level adopted was 5% 
(P-value <0.05). For execution of analysis it was used Statis-
tic Analysis System (SAS) software for Windows version 9.2.
RESULTS
Of 187 patients selected for study, 154 (82.3%) were 
female and 33 (17.7%) were male. The mean age at surgery 
was 40 (range, 18-66) years. Main subject characteristics at 
baseline are summarized on Table 1.
Mean hospital stay was 4.2 ± 0.4 days. Overall surgical 
morbidity was 10.7% and the commonest complication was 
wound infection (6.4%). There was no mortality. Patients 
experienced a significant mean BMI decrease from 38.5 ± 
3 kg/m2 to 27 ± 3.7 kg/m2 (P<0.001). Mean weight loss was 
30.4 ± 11.2 kg (P<0.0001). Mean percentage of excess weight 
loss after surgery was 84.7 ± 27.7%.
Surgical failure (%EWL below 50%) was observed in 21 
subjects (11.2%). Advanced age (P = 0.0209) and type 2 dia-
betes mellitus (P = 0.0460) presented a statistically significant 
association with weight loss failure. Table 2 shows compar-
isons of demographic features, anthropometric parameters, 
and comorbidity profile between the groups (surgical failure 
vs. adequate excess weight loss).
DISCUSSION
Weight loss failure following classical RYGB has been 
recognized and its previously reported rates are highly 
variable, occurring in 15%-35% of  cases(2, 16, 18, 23). It is 
also much more prevalent in the superobese population, 
where failure to achieve a BMI below 35 kg/m2 occurs in 
up to 60%(16, 18, 20, 24). The prevalence observed in this study 
(11.2%) was slightly below those previously reported, but 
it is possible that it might get higher in a later evaluation; 
furthermore, as our population did not include any super-
obese subject, it might be responsible for underestimating 
the impact of  failure following RYGB.
This study showed that advanced age and T2DM, as it 
has been previously identified(11, 13, 14, 17), were predictors of 
poorer weight loss following RYGB. This finding may be 
linked to metabolic changes associated to the ageing process 
and abnormalities in glycemic and insulinemic homeostasis 
related to T2DM(4). Moreover, RYGB has previsouly shown 
lower improvement rates for T2DM and insulin resistance 
than biliopancreatic diversions(9).
Since it has a concerning prevalence in mid to long-term 
follow-up, several surgical interventions have been proposed as 
alternatives to treat it with varying reported degrees of success. 
No consensus has been reached on the favored operation of 
choice for RYGB revision(18). There are reports of procedures 
that reinforced the restrictive component of  the primary 
surgery, through endoscopic placation, surgical reduction of 
pouch and application of adjustable gastric banding over the 
dilated pouch. Although the good early results reported, these 
procedures have not led to significant long-term outcomes. 
Furthermore, surgical pouch reduction was associated with 
significant morbidity(9, 18). Other groups proposed the addition 
of a malabsorptive component to the predominantly restrictive 
gastric bypass by increasing the length of the Roux limb (distal 
RYGB)(16, 18, 23) or conversion to biliopancreatic diversion(2, 15). 
Despite the possibly durable weight loss after these procedures, 
it is widely accepted that this type of revisional surgery has 
a significantly greater risk of complications, especially the 
protein-calorie malnutrition (PCMN)(2, 16, 18, 23).
Hence, as it is possible to identify subgroups for which 
RYGB may not be the most successful intervention, it can 
be proposed other techniques or changes in classical RYGB, 
TABLE 1. Patients’ characteristics at baseline
Age (years) 40 ± 10.3 (range, 18-66)
Gender
   Masculine
   Female
33 (17.7%)
154 (82.3%)
BMI (kg/m2) 38.5 ± 3 (range, 35-46.2)
T2DM 94 (50.3%)
Hypertension 110 (58.8%)
Insulin usage 21 (11.2%)
BMI: body mass index; T2DM: type 2 diabetes mellitus
TABLE 2. Correlation of demographic features, body mass index and comorbidity profile with weight loss failure
Failure Non-failure P-Value
Age (years) 45.1 ± 9.8 (range, 25-58) 39.1 ± 10.1 (range, 18-65) 0.0209
Gender
   Male






Preoperative BMI (kg/m2) 37.8 ± 2.8 (range, 35-45.3) 38.8 ± 3 (range, 35-46.2) 0.2090
%EWL 37.6 ± 12.6% (range, 3-49.3) 87.3% ± 23 (range, 50.5-166.6) <0.0001
T2DM 15 (71.4%) 79 (47.6%) 0.0460
Hypertension 15 (71.4%) 95 (57.3%) 0.2184
Insulin usage 5 (23.8%) 16 (9.6%) 0.0619
BMI: body mass index; %EWL: percentage of excess weight loss; T2DM: type 2 diabetes mellitus
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such as distal RYGB or duodenal switch, as first surgical 
choice in order to avoid further interventions(7). In regard of 
duodenal switch, the possibility of a slightly higher occur-
rence of early complications must be taken into account(7, 14). 
Nevertheless, it is important to emphasize preoperatively the 
importance of adherence to long-term follow-up, as subjects 
who undergo malabsorptive procedures should be thoroughly 
apprised of the nutritional/metabolic risks and the need for 
frequent postoperative laboratory studies(2).
Although percentage excess weight loss cannot be con-
sidered a unique measurement to assess surgical success, it is 
an important outcome, since it is directly linked to patients’ 
expectations and is enrolled in the process of resolution of 
some comorbidities(6). On the other hand, even subjects who 
do not achieve %EWL above 50% may obtain benefits from 
the procedure. This is observed, for example, in regard of 
insulin resistance and diabetes, whose early improvement is 
clearly partially linked to the anatomical changes brought 
by surgery and not just to weight loss itself(3, 5, 10, 21). Hence, 
weight loss outcomes and expectations should be carefully 
discussed preoperatively between multidisciplinary team and 
patients in order to bring a realistic overview of the surgical 
techniques, their benefits, risks, and limitations.
CONCLUSION
Advanced age and diabetes were identified as predictors 
for weight loss failure following RYGB.
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